Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Co-Diagnostics, Inc.

NASDAQ: CODX · Industrial Applications and Services · 11 alerts · CIK 1692415

Share price
$0.2249Close, Nov 16
Market cap
$2.36M
Shares outstanding
10.51MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Co-Diagnostics, Inc. filings on SEC EDGAR ↗

4:07 PM ET 10-Q
Financial Results

Co-Diagnostics Q3 2026 Results: Net Loss of $6.31M, Loss Widens

Co-Diagnostics, Inc. reported a net loss of $21.7 million for the nine months ended September 30, 2026, compared to a $21.2 million loss in the prior year. Total revenue increased to $594,966 from $358,567, while cash and cash equivalents significantly decreased to $714,803 from $11.9 million at the start of the year.

Key figure
Net loss $6.31M
8:02 AM ET 8-K
Financial Results

Co-Diagnostics Financial Results

Co-Diagnostics reported Q3 2026 financial results, highlighting a 12% year-over-year reduction in operating expenses and the submission of a 510(k) premarket notification to the FDA for its Flu A/B & RSV test. The company also expanded its platform capabilities through a collaboration with ReadyGo Diagnostics and the launch of cloud infrastructure in India.

Term
Q3 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.